Medical devices, healthcare technology and the business of care
PMA approval · P990080

CEEON EDGE FOLDABLE ULTRAVIOLET LIGHT-ABSORBING POSTERIOR CHAMBER INTRAOCULAR LENS, MODEL 911A

Johnson & Johnson Surgical Vision, Inc. · Decision date Apr 5, 2001

MEDTECHLEDGER EXPLANATIONP990080

What did the FDA approve?

The FDA database records an approval dated April 5, 2001, for the CEEON EDGE foldable ultraviolet light-absorbing posterior chamber intraocular lens, model 911A, from Johnson & Johnson Surgical Vision, Inc. The device is described as indicated for primary implantation for visual correction of aphakia in persons 60 years of age or older after cataractous lens removal by phacoemulsification, with placement intended in the capsular bag.

This entry is an original PMA approval, not a supplement. The record does not state a supplement type or supplement reason, and no clinical performance data, comparative outcomes, or safety findings are included. The stated purpose is limited to the indication language in the approval statement; the record does not provide independent evidence of effectiveness beyond that reported purpose.

FDA approval order statement

APPROVAL FOR THE CEEON(TM) EDGE FOLDABLE ULTRAVIOLET LIGHT-ABSORBING POSTERIOR CHAMBER INTRAOCULAR LENS - MODEL 911A. THIS DEVICE IS INDICATED FOR PRIMARY IMPLANTATION FOR THE VISUAL CORRECTION OF APHAKIA IN PERSONS 60 YEARS OF AGE OR OLDER IN WHOM A CATARACTOUS LENS HAS BEEN REMOVED BY PHACOEMULSIFICATION. THE LENS IS INTENDED TO BE PLACED IN THE CAPSULAR BAG.
Regulatory pathway
Original PMA
Clinical specialty
Ophthalmic
Decision date
Apr 5, 2001

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P990080
Regulatory pathway
Premarket approval application
Product code
HQL
Decision code
APPR
Decision date
Apr 5, 2001
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: intraocular lens.

Product code
HQL
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P990080 received

    Application receipt date recorded by FDA.

  2. P990080 · FDA decision

    APPR

  3. P990080/S067 · Related supplement

    TECNIS Foldable Acrylic IOL with OptiEdge, Model ZA9003

Timeline entries are records held by MedtechLedger for P990080. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P990080

Product / regulatory recordCompanyPathwayDecision dateSource
Johnson & Johnson Surgical Vision, Inc.PMA supplementOct 19, 2026FDA

Explore the linked device profile

Other records with product code HQL

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Johnson & Johnson Surgical Vision, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
31 Technology Dr., Suite 200, Irvine, CA, 92618

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records